Fibroblast growth factor 14
AssigneeHuman Genome Sciences, Inc.
InventorsJohn M. Greene, Patrick J. Dillon
Life of this patent
Estimating the term…
Loading patent…
AssigneeHuman Genome Sciences, Inc.
InventorsJohn M. Greene, Patrick J. Dillon
Estimating the term…
Disclosed is a human Fibroblast growth factor-14 polypeptide and DNA(RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques. Also disclosed are methods for utilizing such polypeptide for promoting wound healing for example as a result of burns and ulcers, to prevent neuronal damage due to associated with stroke and promote neuronal growth, and to prevent skin aging and hair loss, to stimulate angiogenesis, mesodermal induction in early embryos and limb regeneration. Antagonists against such polypeptides and their use as a therapeutic to prevent abnormal cellular proliferation, hyper-vascular diseases and epithelial lens cell proliferation are also disclosed. Diagnostic methods for detecting mutations in the coding sequence and alterations in the concentration of the polypeptides in a sample derived from a host are also disclosed.
An isolated nucleic acid molecule comprising a nucleic acid sequence encoding at least 30 contiguous amino acids of SEQ ID NO:2.
An isolated recombinant host cell comprising the nucleic acid molecule of 1, wherein said nucleic acid molecule is operatively associated with a heterologous regulatory sequence.
An isolated nucleic acid molecule comprising a polynucleotide selected from the group consisting of:
An isolated nucleic acid molecule comprising a polynucleotide selected from the group consisting of:
Dependencies are inferred from the claim text.